Freedman Financial Associates, Inc. Pfizer Inc Transaction History

Freedman Financial Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $473,908 - $561,906	-10,185 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$45.75 - $56.69 $29,188 - $36,168	638 Added 6.68%	10,185 $519,000
Q4 2021 Jan 14, 2022	SELL	$41.32 - $61.25 $2,189 - $3,246	-53 Reduced 0.55%	9,547 $564,000
Q3 2021 Oct 08, 2021	BUY	$39.25 - $50.42 $4,160 - $5,344	106 Added 1.12%	9,600 $413,000
Q2 2021 Jul 13, 2021	SELL	$35.91 - $40.68 $61,046 - $69,156	-1,700 Reduced 15.19%	9,494 $372,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $10,047 - $11,331	-300 Reduced 2.61%	11,194 $406,000
Q4 2020 Feb 17, 2021	BUY	$33.47 - $42.56 $384,704 - $489,184	11,494 New	11,494 $423,000

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Freedman Financial Associates, Inc. with notifications on news.